文献速递糖尿病

发展中国家2型糖尿病患者血糖控制持续不佳:国际糖尿病管理实践研究(IDMPS)12年真实世界证据

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
PubMed 文献 · Diabetologia · 2020-01-04

国际糖尿病管理实践研究在2005-2017年七个横断面波次中,从49个国家6099名医生处连续纳入66088例2型糖尿病患者,评估血糖控制趋势。HbA1c<53 mmol/mol(<7%)的比例从第1波36%降至第7波30.1%(p<0.0001),调整后达到HbA1c≤64 mmol/mol(≤8%)的OR在第2、5、6、7波较第1波显著下降(p<0.05),胰岛素使用从32.8%升至41.2%。结论认为发展中国家2型糖尿病血糖控制12年间仍不理想,需要系统改变和更好的照护组织。

要点

  • HbA1c<53 mmol/mol(<7%)的比例从第1波(2005年)36%降至第7波(2017年)30.1%(p<0.0001)。
  • 与第1波相比,达到HbA1c≤64 mmol/mol(≤8%)的调整后OR在第2、5、6、7波显著下降(p<0.05)。
  • 胰岛素使用从第1波32.8%升至第7波41.2%(p<0.0001),口服降糖药使用超过80%且磺脲类使用下降。

核心结论

  • 在发展中国家,2型糖尿病患者的血糖控制在12年期间仍不理想,提示需要系统改变和更好的照护组织以改善自我管理和实现治疗目标。

研究设计与样本

  • 国际糖尿病管理实践研究(IDMPS)在发展中国家开展七个横断面波次(2005-2017年),提供患者特征和糖尿病照护实践的真实世界证据。
  • 每个波次中,每位医生在2周期间连续收集10例2型糖尿病参与者的数据。
  • 共从49个国家的6099名医生处招募66088例2型糖尿病患者。

主要发现

  • HbA1c<53 mmol/mol(<7%)的参与者比例从第1波(2005年)36%降至第7波(2017年)30.1%(p<0.0001)。
  • 与第1波相比,达到HbA1c≤64 mmol/mol(≤8%)的调整后OR在第2、5、6、7波显著下降(p<0.05)。
  • 超过80%的参与者接受口服降糖药,磺脲类使用下降;胰岛素使用从第1波32.8%升至第7波41.2%(p<0.0001)。
  • 起始胰岛素的时间(均值±标准差)从第1波8.4±6.9年变为第7波8.3±6.6年;基础方案每日胰岛素剂量从第1波0.39±0.21 U/kg至第7波0.33±0.19 U/kg,基础-餐时方案从第1波0.70±0.34 U/kg至第7波0.77±0.33 U/kg。
  • 入组12个月内HbA1c测量≥2次的参与者比例从61.8%升至92.9%,接受糖尿病教育(主要由医生提供)的比例从59.0%升至78.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We evaluated the secular trend of glycaemic control in individuals with type 2 diabetes in developing countries, where data are limited. METHODS: The International Diabetes Management Practices Study provides real-world evidence of patient profiles and diabetes care practices in developing countries in seven cross-sectional waves (2005-2017). At each wave, each physician collected data from ten consecutive participants with type 2 diabetes during a 2 week period. The primary objective of this analysis was to evaluate trends of glycaemic control over time. RESULTS: A total of 66,088 individuals with type 2 diabetes were recruited by 6099 physicians from 49 countries. The proportion of participants with HbA1c <53 mmol/mol (<7%) decreased from 36% in wave 1 (2005) to 30.1% in wave 7 (2017) (p < 0.0001). Compared with wave 1, the adjusted ORs of attaining HbA1c ≤64 mmol/mol (≤8%) decreased significantly in waves 2, 5, 6 and 7 (p < 0.05). Over 80% of participants received oral glucose-lowering drugs, with declining use of sulfonylureas. Insulin use increased from 32.8% (wave 1) to 41.2% (wave 7) (p < 0.0001). The corresponding time to insulin initiation (mean ± SD) changed from 8.4 ± 6.9 in wave 1 to 8.3 ± 6.6 years in wave 7, while daily insulin dosage ranged from 0.39 ± 0.21 U/kg (wave 1) to 0.33 ± 0.19 U/kg (wave 7) for basal regimen and 0.70 ± 0.34 U/kg (wave 1) to 0.77 ± 0.33 (wave 7) U/kg for basal-bolus regimen. An increasing proportion of participants had ≥2 HbA1c measurements within 12 months of enrolment (from 61.8% to 92.9%), and the proportion of participants receiving diabetes education (mainly delivered by physicians) also increased from 59.0% to 78.3%. CONCLUSIONS: In developing countries, glycaemic control in individuals with type 2 diabetes remained suboptimal over a 12 year period, indicating a need for system changes and better organisation of care to improve self-management and attainment of treatment goals.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Aschner P, Gagliardino JJ, Ilkova H, et al. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS). Diabetologia. 2020. PMID: 31901950. doi:10.1007/s00125-019-05078-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。